Location History:
- Guildford, GB (1989 - 2000)
- Surrey, GB (2002)
- Basingstoke, GB (2009)
Company Filing History:
Years Active: 1989-2009
Title: The Innovations of John Richard Harris: A Pioneer in Pharmaceutical Patents
Introduction: John Richard Harris, an accomplished inventor based in Guildford, GB, has made significant contributions to the field of pharmaceuticals with a total of nine patents to his name. His innovative work focuses primarily on compounds that serve as inhibitors for monoamine uptake, which play a crucial role in treating various neurological disorders.
Latest Patents: Harris's latest patents showcase his expertise in developing compounds that can act on the central and peripheral nervous systems. One of his recent inventions includes "Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake." This invention presents compounds that target the uptake of neurotransmitters such as serotonin, norepinephrine, and dopamine. The potential applications of these compounds could prove essential in addressing disorders affecting the nervous system.
Another notable patent is the "Use of n-substituted (3,6-dihydro)-2H-1,2-oxazine derivatives as selective mGluR1 antagonists." This patent describes various compounds that could yield therapeutic benefits through the selective inhibition of the mGluR1 receptor, thereby offering promising avenues for treating specific conditions that necessitate the use of such antagonists.
Career Highlights: Throughout his career, John Richard Harris has held positions in prestigious companies such as Eli Lilly and Company and Lilly Industries, Inc. These roles have afforded him the opportunity to translate his innovative ideas into practical applications that benefit the field of medicine.
Collaborations: Harris has worked alongside esteemed colleagues in the industry, including Barry P. Clark and Jeremy Gilmore. Their collaborative endeavors have likely enhanced the development of Harris's groundbreaking inventions, pooling together diverse knowledge and expertise in the pharmaceutical arena.
Conclusion: John Richard Harris stands out as a prominent inventor pushing the boundaries of pharmaceutical innovation. With nine patents that reflect his dedication to enhancing the treatment of neurological disorders, Harris’s work continues to have a lasting impact on the medical community. His journey exemplifies the vital role of inventors in advancing healthcare and improving patient outcomes through innovative solutions.